Home » Heart Valves: St. Jude Medical Champions Trifecta Data

Heart Valves: St. Jude Medical Champions Trifecta Data

March 25, 2013

St. Jude Medical championed newly published results from the 4-year-old study it used to back its premarket approval application for the Trifecta heart valve in The Journal of Thoracic and Cardiovascular Surgery.
MassDevice

04Apr
Optimizing Quality Control Operations with Unified Quality
12Apr
The Patient Playbook Webinar Series, Part 3 — Rethinking the Development of Participant-Centric Clinical Trial Technology
20Apr
Medical Device Enforcement: Latest Developments from the FDA, DOJ and FTC
25Apr
Effective Root Cause Analysis and CAPA Investigations for Drugs, Devices and Clinical Trials
26Apr
FDA’s New Laws and Regulations: What Drug and Biologics Manufacturers Need to Know
26Apr
Building the Foundation for QMS AI

Heart Valves: St. Jude Medical Champions Trifecta Data

Upcoming Events

Optimizing Quality Control Operations with Unified Quality

The Patient Playbook Webinar Series, Part 3 — Rethinking the Development of Participant-Centric Clinical Trial Technology

Medical Device Enforcement: Latest Developments from the FDA, DOJ and FTC

Effective Root Cause Analysis and CAPA Investigations for Drugs, Devices and Clinical Trials

FDA’s New Laws and Regulations: What Drug and Biologics Manufacturers Need to Know

Building the Foundation for QMS AI

Featured Products

FDA’s New Quality System Regulation: Transitioning from QSR to ISO 13485

Selecting and Implementing Electronic Document Management Systems in the EU

Featured Stories

Surmodics Gets FDA’s Feedback on Rejected PMA

EU Approves Amicus Therapeutics Pombiliti for Late-Onset Pompe Disease

FDA Final Order Requires PMA for Spinal Spheres

FDA and Lupus Research Alliance Form Drug Development Consortium

The Revised ICH E8: A Guide to New Clinical Trial Requirements